Srinivasa Reddy Battula

Title: Srinivasa Reddy Battula: A Visionary Inventor in Pharmaceutical Innovations

Introduction

Srinivasa Reddy Battula is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, holding three patents that showcase his innovative spirit and dedication to therapeutic advancements. His work primarily focuses on developing novel compounds that demonstrate serotonin receptor affinity, which are crucial in therapeutic applications.

Latest Patents

Srinivasa Reddy Battula's latest patents include groundbreaking inventions such as:

1. **Tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them**. This patent relates to novel tetracyclic arylsulfonyl indoles and their various forms including derivatives, analogues, tautomeric forms, stereoisomers, polymorphs, and pharmaceutically acceptable salts. The invention outlines processes for preparation and compositions that contain these compounds for therapeutic use.

2. **Tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them**. Similar to the previous patent, this invention details novel tetracyclic arylcarbonyl indoles, emphasizing their potential as therapeutic agents. It also covers a wide array of chemical forms, preparation processes, and applications in therapy.

Career Highlights

Srinivasa Reddy Battula currently works at Suven Life Sciences Limited, a company recognized for its commitment to pharmaceutical innovation and research. His career is marked by a relentless pursuit of advancements that can significantly impact therapeutic practices across various medical disciplines.

Collaborations

Throughout his career, Srinivasa has collaborated with esteemed colleagues such as Venkateswarlu Jasti and Venkata Satya Nirogi Ramakrishna. These collaborations have enhanced research capabilities and fostered innovation in the field, allowing for a broader exploration of therapeutic possibilities.

Conclusion

Srinivasa Reddy Battula exemplifies the spirit of innovation in pharmaceuticals through his inventive works and collaborative efforts. His patents, which focus on serotonin receptor-affinity compounds, underscore the potential for significant advancements in therapeutic agents. He continues to be a valuable asset to Suven Life Sciences Limited and the broader scientific community, driving forward the frontiers of pharmaceutical research.